Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Margaret Bassendine.

Newcastle AuthorsTitleYearFull text
Dr David Sheridan
Professor Margaret Bassendine
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease2015
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Fiona Fenwick
Dr Clare Lanyon
et al.
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism2015
Professor Margaret Bassendine
Dr David Sheridan
Jaime Jonsson
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection2013
Dr David Sheridan
Dr R Neely
Professor Margaret Bassendine
Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)2013
Professor Margaret Bassendine
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
et al.
Lipids and HCV2013
Professor Margaret Bassendine
Dr Stuart McPherson
Liver Stiffness Measurement Assessed by Fibroscan Predicts Response to Anti-Viral Treatment in Patients with Genotype 2 and 3 Chronic Hepatitis C2013
Dr Matthias Schmid
Professor Margaret Bassendine
Dr Stuart McPherson
Liver Stiffness Measurement Predicts Response to Anti-Viral Treatment in Patients with Chronic Hepatitis C Genotype 32013
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Fiona Fenwick
Professor Geoff Toms
et al.
Metabolic Syndrome and Insulin Resistance are Associated with Maximum Hepatitis C Lipoviral Particles in Genotype 1 Infection2013
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Fiona Fenwick
Professor Margaret Bassendine
et al.
Omega-3 Fatty Acids and/or Fluvastatin in Hepatitis C Prior Non-Responders to Combination Anti-Viral Therapy - A Pilot Randomised Clinical Trial2013
Dr Stuart McPherson
Dr Samuel Moses
Professor Margaret Bassendine
Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England2013
Dr Stuart McPherson
Dr Samuel Moses
Dr Shafiq Rehman
Claire Miller
Dr Mark Hudson
et al.
A pilot of targeted case finding for hepatitis B virus (HBV) and hepatitis C (HCV) in the British South Asian community2012
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Professor Geoff Toms
Dr R Neely
et al.
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity2012
Dr Enid Michael
Dr Andrew Turley
Dr Samuel Moses
Dr Mark Hudson
Professor Margaret Bassendine
et al.
Pregnant mothers with chronic hepatitis B (HBV): how often is treatment needed?2012
Professor Margaret Bassendine
Dr David Sheridan
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study2011
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Professor Geoff Toms
Professor Margaret Bassendine
et al.
Apolipoprotein E and low-density, apolipoprotein B associated lipoviral particles in chronic Hepatitis C infection: Evidence for genotype-specific modulation of lipid pathways2011
Professor Margaret Bassendine
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Professor Geoff Toms
et al.
HCV and the hepatic lipid pathway as a potential treatment target2011
Dr Stuart McPherson
Dr Mark Hudson
Professor Margaret Bassendine
Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England2011
Dr Stuart McPherson
Dr Mark Hudson
Professor Margaret Bassendine
Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England2011
Dr Daniel Felmlee
Dr David Sheridan
Dr Simon Bridge
Professor Geoff Toms
Professor Margaret Bassendine
et al.
Use of intralipid infusion to analyse apolipoprotein B (APOB) and HCV RNA kinetics in chronic infection2011
Dr R Neely
Professor Margaret Bassendine
Antisense technology to lower LDL cholesterol2010
Dr David Sheridan
Professor Kim Bartlett
Dr Daniel Felmlee
Dr Simon Bridge
Professor Geoff Toms
et al.
Hypocholesterolaemia in chronic hepatitis C genotype 3 infection is due to both reduced cholesterol production and increased LDL clearance2010
Dr David Sheridan
Professor Kim Bartlett
Dr Daniel Felmlee
Dr Simon Bridge
Professor Geoff Toms
et al.
Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection - Reduced production or increased LDL clearance?2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Dr Soren Nielsen
Dr R Neely
et al.
Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Dr Soren Nielsen
Dr R Neely
et al.
Insulin resistance correlates with low density hepatitis C virus particles in genotype 1 infection2010
Dr Daniel Felmlee
Dr David Sheridan
Dr Simon Bridge
Dr Soren Nielsen
Professor Geoff Toms
et al.
Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Professor Geoff Toms
Dr R Neely
et al.
Low density Hepatitis C virus particles (lipoviral particles) associate with insulin resistance in genotype 1 infection2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Professor Geoff Toms
Professor Margaret Bassendine
et al.
Measurement of low-density Apolipoprotein B associated lipoviral particles in hepatitis C virus genotype 1 infection is more clinically relevant than total viral load2010
Dr Mark Hudson
Dr Stuart McPherson
Professor Alastair Burt
Professor Margaret Bassendine
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus2010
Dr Mark Hudson
Dr Stuart McPherson
Professor Alastair Burt
Professor Margaret Bassendine
Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus2010
Dr Daniel Felmlee
Dr David Sheridan
Dr Simon Bridge
Professor Geoff Toms
Professor Margaret Bassendine
et al.
The HCV life-cycle in the vascular compartment2010
Dr Monique Welten
Professor Margaret Bassendine
Dr David Sheridan
Dr James George
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy2009
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Dr Soren Nielsen
Professor Geoff Toms
et al.
Apolipoprotein B Associated Hepatitis C Virus (HCV): A Minority of Total Viral Load in Patients with Chronic HCV2009
Dr David Sheridan
Dr David Price
Dr Matthias Schmid
Professor Geoff Toms
Dr Peter Donaldson
et al.
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin2009
Dr Lucy Walker
Professor Julia Newton
Professor David Jones
Professor Margaret Bassendine
Comment on Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis in Primary Biliary Cirrhosis2009
Dr Daniel Felmlee
Dr Simon Bridge
Dr David Sheridan
Dr Soren Nielsen
Professor Geoff Toms
et al.
Large and Buoyant Hepatitis C Virus (HCV) Particles Surge after Patients Consume a High-Fat Meal2009
Sarah Welsh
Dr Soren Nielsen
Emeritus Professor Alan Ward
Professor Margaret Bassendine
Analysis of reactivity of PBC sera with bacterial antigens modified by xenobiotic exposure2008
Dr Soren Nielsen
Siti Ibrahim
Professor Margaret Bassendine
Professor Geoff Toms
Binding of liver derived, low density hepatitis C virus to human hepatoma cells2008
Dr Soren Nielsen
Professor Margaret Bassendine
Caroline Martin
Daniel Lowther
Dr Paul Purcell
et al.
Characterization of hepatitis C RNA-containing particles from human liver by density and size2008
Dr Soren Nielsen
Professor Margaret Bassendine
Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies2008
Dr Martin Prince
Professor Margaret Bassendine
Dr Mark Hudson
Emeritus Professor Oliver James
Professor David Jones
et al.
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis2007
Dr Soren Nielsen
Professor Margaret Bassendine
Professor Geoff Toms
Characterization of hepatitis C RNA containing particles from human liver by density and morphology2007
Dr Soren Nielsen
Professor Margaret Bassendine
Professor Geoff Toms
Characterization of hepatitis C virus associated with very low density lipoprotein (VLDL) in infected human serum and liver2007
Dr Peter Donaldson
Professor David Jones
Dr John Taylor
Professor Julia Newton
Professor Margaret Bassendine
et al.
Cytotoxic T-Lymphocyte-Associated Antigen-4 Single Nucleotide Polymorphisms and Haplotypes in Primary Biliary Cirrhosis2007
Professor Margaret Bassendine
Lipids and infection2007
Professor Alastair Burt
Dr Mark Hudson
Professor Margaret Bassendine
The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.2007
Dr David Price
Professor Margaret Bassendine
Professor Geoff Toms
Dr Matthias Schmid
Dr Christopher Morris
et al.
Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection2006
Dr Soren Nielsen
Professor Margaret Bassendine
Professor Alastair Burt
Caroline Martin
Dr Wanna Pumeechockchai
et al.
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients2006
Dr David Price
Dr Matthias Schmid
Dr Kaushik Agarwal
Wendy Craig
Professor Alastair Burt
et al.
Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area2006
Professor Margaret Bassendine
Cost effectiveness of interferon α or peginterferon α with ribavirin for histologically mild chronic hepatitis C2006
Dr Soren Nielsen
Professor Margaret Bassendine
Caroline Martin
Professor Geoff Toms
Development of a purification procedure for native hepatitis C virus from human liver2006
Dr Peter Donaldson
Dr Anna Baragiotta
Professor David Jones
Emeritus Professor Oliver James
Professor Margaret Bassendine
et al.
HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: A large-scale study2006
Fiona Fenwick
Professor Margaret Bassendine
Dr Kaushik Agarwal
Professor Debra Bevitt
Dr Wanna Pumeechockchai
et al.
Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation2006
Dr David Price
Dr Peter Donaldson
Julian Leathart
Professor Alastair Burt
Dr Matthias Schmid
et al.
Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis2006
Dr David Price
Professor Alastair Burt
Dr Matthias Schmid
Wendy Craig
Professor Margaret Bassendine
et al.
Steatosis in chronic HCV infection: viral and host characteristics2006
Dr Martin Prince
Professor Margaret Bassendine
Professor David Jones
Fatigue in primary biliary cirrhosis [1]2005
Caroline Martin
Dr Soren Nielsen
Professor Margaret Bassendine
Professor Geoff Toms
Hepatitis C virus lipo-viro-particle interactions with human hepatocytes and inhibition of of binding2005
Dr Soren Nielsen
Professor Alastair Burt
Caroline Martin
Professor Margaret Bassendine
Professor Geoff Toms
et al.
Hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral particles2005
Dr Soren Nielsen
Professor Alastair Burt
Caroline Martin
Professor Margaret Bassendine
Professor Geoff Toms
et al.
Human hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral-particles2005
Professor Margaret Bassendine
Infectious aetiology of primary biliary cirrhosis2005
Professor Matthew Wright
Professor Margaret Bassendine
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: A multicentre randomized controlled trial2005
Dr David Price
Professor Margaret Bassendine
Professor Alastair Burt
Dr Peter Donaldson
Apolipoprotein E2 protects against persistent hepatitis C virus infection2004
Dr Soren Nielsen
Professor Margaret Bassendine
Professor Alastair Burt
Professor Debra Bevitt
Professor Geoff Toms
et al.
Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver2004
Dr Anna Baragiotta
Dr Kaushik Agarwal
Dr Alison Sutherland
Professor David Jones
Dr Peter Donaldson
et al.
Chemokine receptor 5 and primary biliary cirrhosis: A two-centre genetic association study2004
Professor Margaret Bassendine
Professor David Jones
Fatigue and primary biliary cirrhosis: Association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels2004
Dr David Price
Professor Alastair Burt
Professor Margaret Bassendine
Host and viral characteristics associated with steatosis in chronic hepatitis C2004
Dr Anna Baragiotta
Dr Kaushik Agarwal
Professor David Jones
Dr Peter Donaldson
Professor Margaret Bassendine
et al.
No evidence for involvement of the CCR5 (chemokine receptor-5) delta 32 mutation in primary biliary cirrhosis2004
Professor David Jones
Professor Margaret Bassendine
Primary biliary cirrhosis: Report of a focus study group2004
Emeritus Professor Oliver James
Siddesh Jain
Professor Margaret Bassendine
Tamoxifen: A novel treatment for primary biliary cirrhosis?2004
Professor Margaret Bassendine
The Molecular Basis of Primary Biliary Cirrhosis2004
Dr Martin Prince
Professor Margaret Bassendine
A retrospective study of weight loss during alpha-interferon (alpha-IFN) therapy for chronic hepatitis C (HCV)2003
Professor Alastair Burt
Caroline Martin
Professor Margaret Bassendine
Professor Geoff Toms
Association of HCV particles with LDL/VLDL: Analysis using isotonic iodixanol gradient centrifugation & real time PCR2003
Dr John Taylor
Emeritus Professor Oliver James
Professor Margaret Bassendine
Professor David Jones
Dr Peter Donaldson
et al.
Caspase 8 gene polymorphism is associated with primary biliary cirrhosis2003
Dr Soren Nielsen
Professor Margaret Bassendine
Professor Alastair Burt
Professor Geoff Toms
Characterisation of the genome and structural proteins of beta-lipoprotein associated HCV extracted from infected human liver2003
Professor Margaret Bassendine
Primary Biliary Cirrhosis2003
Professor Margaret Bassendine
The Effective Management of Hepatitis C Infection2003
Dr David Price
Dr Kaushik Agarwal
Dr Matthias Schmid
Professor Alastair Burt
Professor Margaret Bassendine
et al.
The hepatitis C virus (HCV) epidemic; spectrum of chronic liver disease in a single UK centre2003
Dr Amanda Robe
Dr Jeremy Palmer
Professor John Kirby
Professor Margaret Bassendine
Professor David Jones
et al.
[abstract] Characterisation of liver infiltrating T-cell antigen specificity in a mouse model of primary biliary cirrhosis (PBC)2002
Dr Martin Prince
Wendy Craig
Dr Matthias Schmid
Professor Margaret Bassendine
A retrospective study of weight loss during alpha-inter feron (alpha-IFN) therapy for chronic hepatitis C (HCV)2002
Dr Anna Baragiotta
Emeritus Professor Oliver James
Wendy Craig
Dr Denis Burke
Dr Malcolm Bateson
et al.
Autoimmune hepatitis (AIH): Clinical spectrum of disease defined by revised international autoimmune hepatitis group (IAHG) scoring system2002
Dr John Taylor
Emeritus Professor Oliver James
Professor Margaret Bassendine
Professor David Jones
Dr Peter Donaldson
et al.
Caspase 8 gene polymorphism is associated with primary biliary cirrhosis2002
Dr Soren Nielsen
Dr Wanna Pumeechockchai
Professor Alastair Burt
Professor Margaret Bassendine
Professor Geoff Toms
et al.
Characterization of HCV RNA particles from the serum of a patient with common variable immunodeficiency on isotonic iodixanol (optiprep) gradients. Association with apolipoprotein-B1002002
Dr Soren Nielsen
Professor Margaret Bassendine
Alison Burt
Professor Geoff Toms
Characterization of the structural proteins of HCV isolated from human liver2002
Dr Kaushik Agarwal
Professor Margaret Bassendine
Hepatitis associated with Chinese herbs2002
Dr Wanna Pumeechockchai
Professor Debra Bevitt
Dr Kaushik Agarwal
Professor Margaret Bassendine
Professor Geoff Toms
et al.
Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody2002
Professor Margaret Bassendine
How to respond to abnormal liver function tests2002
Professor Julia Newton
Emeritus Professor Oliver James
Professor Margaret Bassendine
Professor David Jones
Osteoporosis is not a specific complication of primary biliary cirrhosis2002
Dr Martin Prince
Professor Margaret Bassendine
Professor David Jones
Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis (PBC)2002
Professor Margaret Bassendine
Professor David Jones
Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis [abstract]2002
Dr Birju Rana
Dr Chris Redfern
Professor Derek Manas
Professor Margaret Bassendine
Retinoic acid receptor-selective ligands and hepatocellular carcinoma (HCC)2002
Dr Matthias Schmid
Professor Alastair Burt
Professor Margaret Bassendine
The hepatitis C virus (HCV) epidemic; Spectrum of chronic liver disease in a single UK centre2002
Dr Martin Prince
Dr Anna Baragiotta
Professor Margaret Bassendine
Emeritus Professor Oliver James
Professor David Jones
et al.
The true impact of fatigue in primary biliary cirrhosis: A population study2002
Dr Anna Baragiotta
Professor David Jones
Dr Kaushik Agarwal
Emeritus Professor Oliver James
Professor Margaret Bassendine
et al.
Genetic susceptibility to primary biliary cirrhosis (PBC): Analysis of chemokine receptor 5 (CCR5) delta32 deletion2001
Professor Margaret Bassendine
Dr Raymond Barry
Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: a UK multicentre study2001
Wendy Craig
Emeritus Professor Oliver James
Dr Denis Burke
Professor Melissa Bateson
Professor Margaret Bassendine
et al.
Is the revised international autoimmune hepatitis group (IAHG) scoring system useful?2001
Dr Sarah Jowett
Dr Kaushik Agarwal
Dr Eilish Gilvarry
Professor Alastair Burt
Professor Margaret Bassendine
et al.
Managing chronic hepatitis C acquired through intravenous drug use2001
Dr Sarah Jowett
Dr Kaushik Agarwal
Dr Eilish Gilvarry
Professor Alastair Burt
Professor Margaret Bassendine
et al.
Managing chronic hepatitis C acquired through intravenous drug use2001
Professor Julia Newton
Emeritus Professor Roger Francis
Emeritus Professor Oliver James
Professor Margaret Bassendine
Professor David Jones
et al.
Osteoporosis in primary biliary cirrhosis revisited2001
Dr Alberto Lopes
Professor Margaret Bassendine
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation2001
Dr Anna Baragiotta
Emeritus Professor Oliver James
Professor Melissa Bateson
Professor Margaret Bassendine
Validation of the revised International Autoimmune Hepatitis Group (IAHG) scoring system: Experience in the north of England2001
Dr Anna Baragiotta
Emeritus Professor Oliver James
Professor David Jones
Joanne Newton
Professor Margaret Bassendine
et al.
Vitamin D receptor (VDR) TaqI polymorphism in primary biliary cirrhosis (PBC)2001
Professor David Jones
Professor Ann Daly
Emeritus Professor Oliver James
Dr Bijayeswar Vaidya
Professor Simon Pearce
et al.
CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis2000
Professor Ann Daly
Professor Margaret Bassendine
Professor Chris Day
Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease2000
Dr Jeremy Palmer
Professor John Kirby
Emeritus Professor Steve Yeaman
Professor Margaret Bassendine
Professor David Jones
et al.
Secretory autoantibodies in primary biliary cirrhosis (PBC)2000
Dr Mark Welfare
Professor Margaret Bassendine
Professor Ann Daly
The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects2000
Dr Margaret Jackson
Professor Debra Bevitt
Professor Geoff Toms
Professor Margaret Bassendine
Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals1999
Dr Kaushik Agarwal
Professor David Jones
Professor Ann Daly
Professor Margaret Bassendine
CTLA-4 gene polymorphism and chronicity in viral hepatitis1999
Dr Kaushik Agarwal
Professor David Jones
Professor Ann Daly
Professor Margaret Bassendine
Dr Mark Hudson
et al.
CTLA-4 gene polymorphism and susceptibility to inflammatory bowel disease (IBD)1999
Dr Mark Welfare
Emeritus Professor Murray Aitkin
Professor Margaret Bassendine
Professor Ann Daly
Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: Lack of a polymorphism in CYP1A2 in Caucasians1999
Marian Case
Professor Alastair Burt
Joan Hughes
Dr Jeremy Palmer
Professor Margaret Bassendine
et al.
Erratum to 'Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol' (Journal of Immunological Methods (1999) 223 (93-106))1999
Professor David Jones
Professor Margaret Bassendine
Emeritus Professor Oliver James
Familial primary hiliary cirrhosis reassessed: A geographically-based population study1999
Dr Kaushik Agarwal
Professor David Jones
Professor Margaret Bassendine
Genetic susceptibility to primary biliary cirrhosis [Review]1999
Dr Peter Donaldson
Dr Kaushik Agarwal
Emeritus Professor Oliver James
Professor Margaret Bassendine
Interleukin-1 beta gene polymorphisms are associated with disease progression in primary biliary cirrhosis1999
Dr Sarah Jowett
Dr Kaushik Agarwal
Professor Margaret Bassendine
Medical management of chronic hepatitis C in intravenous drug users1999
Professor Margaret Bassendine
Professor Ann Daly
Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer1999
Dr Jeremy Palmer
Emeritus Professor Steve Yeaman
Professor Margaret Bassendine
Professor David Jones
T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC)1999
Professor David Jones
Professor Julia Newton
Professor Ann Daly
Professor Chris Day
Emeritus Professor Oliver James
et al.
Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis1999
Professor David Jones
Emeritus Professor Oliver James
Professor Margaret Bassendine
Primary biliary cirrhosis: clinical and associated autoimmune features and natural history1998
Professor Ann Daly
Professor Margaret Bassendine
Emeritus Professor Oliver James
Professor Chris Day
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: Effect on age of presentation and dependence on alcohol dehydrogenase genotype1998
Professor Debra Bevitt
Dr Gavin Spickett
Professor Geoff Toms
Professor Margaret Bassendine
Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: A comparison of immunodeficient and immunocompetent patients1996
Professor Helen Reeves
Professor Derek Manas
Professor Margaret Bassendine
Dr Mark Hudson
Emeritus Professor Oliver James
et al.
Intravenous bisphosphonate pre liver transplant prevents osteoporotic vertebral collapse1996
Dr Kun Guo
Dr Felicity May
Dr Mark Bennett
Dr Ian Corbett
Professor Margaret Bassendine
et al.

C-erbb-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma

1992
Dr Christine Challen
Professor John Lunec
Professor Margaret Bassendine
Analysis of the p53 tumour suppressor gene in HCCs from Britain.1992
Dr Christine Challen
Professor Margaret Bassendine
Infrequent point mutations in codons 12 and 61 of Ras oncogenes in HCC.1992
Professor John Lunec
Professor Margaret Bassendine
P53 - A frequent target for genetic abnormalities in human hetatocellular carcinomas (HCCS) in Britain1991
Professor Margaret Bassendine
Professor Nicola Curtin
Dr Henry Loose
Emeritus Professor Oliver James
Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study.1987
Professor Margaret Bassendine
Professor Nicola Curtin
Emeritus Professor Oliver James
A new thymidylate synthase (TS) inhibitor, CB3717, in human primary liver cancer (PLC) - invitro, xenograft and phase-II studies1986
Professor Margaret Bassendine
Professor Nicola Curtin
Emeritus Professor Oliver James
Induction of remission in primary liver cell cancer PLC with a new thymidylate synthase inhibitor, CB3717: a phase II study1986
Professor Nicola Curtin
Emeritus Professor Oliver James
Professor Margaret Bassendine
Inhibition of the growth of human hepatocellular-carcinoma invitro and in athymic mice by a quinazoline inhibitor of thymidylate suntjase, CB37171986
Emeritus Professor Oliver James
Professor Nicola Curtin
Professor Margaret Bassendine
Primary hepatocellular carcinoma localised by a radiolabelled monoclonal antibody1986
Emeritus Professor Oliver James
Professor Margaret Bassendine
Professor Nicola Curtin
Localization of primary hepatocellular carcinoma by a radiolabeled monoclonal antibody1985
Emeritus Professor Oliver James
Professor Margaret Bassendine
Professor Nicola Curtin
Primary hepatocellular carcinoma localization using a radiolabeled monoclonal antibody1985
Professor Margaret Bassendine
Emeritus Professor Oliver James
Professor Nicola Curtin
Localization of primary hepatocellular carcinoma using a radiolabeled monoclonal antibody1984
Professor Margaret Bassendine
Professor Nicola Curtin
Emeritus Professor Oliver James
Successful treatment of human primary liver cancer xenograft by new quinazoline anti folate agent CB 37171983